Futura Medical (LON:FUM) Posts Quarterly Earnings Results

Futura Medical (LON:FUMGet Free Report) posted its earnings results on Tuesday. The company reported GBX (0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%.

Futura Medical Price Performance

FUM stock traded down GBX 0.05 during trading on Thursday, hitting GBX 0.28. The stock had a trading volume of 18,645,404 shares, compared to its average volume of 9,214,374. Futura Medical has a twelve month low of GBX 0.20 and a twelve month high of GBX 10.45. The company’s 50-day moving average price is GBX 0.42 and its two-hundred day moving average price is GBX 0.78. The stock has a market capitalization of £1.62 million, a P/E ratio of -0.10 and a beta of 0.02.

About Futura Medical

(Get Free Report)

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.

See Also

Earnings History for Futura Medical (LON:FUM)

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.